Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Current Taxes (2022 - 2025)

Oramed Pharmaceuticals (ORMP) has disclosed Current Taxes for 3 consecutive years, with $11000.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Current Taxes changed N/A year-over-year to $11000.0, compared with a TTM value of $11000.0 through Sep 2024, changed N/A, and an annual FY2023 reading of $11000.0, changed 0.0% over the prior year.
  • Current Taxes was $11000.0 for Q3 2024 at Oramed Pharmaceuticals, roughly flat from $11000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $11000.0 in Q4 2022 and bottomed at $11000.0 in Q4 2022.
  • Average Current Taxes over 3 years is $11000.0, with a median of $11000.0 recorded in 2022.
  • Peak annual rise in Current Taxes hit 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
  • Year by year, Current Taxes stood at $11000.0 in 2022, then changed by 0.0% to $11000.0 in 2023, then changed by 0.0% to $11000.0 in 2024.
  • Business Quant data shows Current Taxes for ORMP at $11000.0 in Q3 2024, $11000.0 in Q2 2024, and $11000.0 in Q1 2024.